• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

一种人类血浆因子诱导的微小病变样肾小球改变。

Minimal change-like glomerular alterations induced by a human plasma factor.

作者信息

Cheung P K, Klok P A, Bakker W W

机构信息

Department of Pathology, University of Groningen, The Netherlands.

出版信息

Nephron. 1996;74(3):586-93. doi: 10.1159/000189457.

DOI:10.1159/000189457
PMID:8938686
Abstract

Circulating factors, including the plasma protease (100 KF) described previously, have been suspected to play a role in the pathogenesis of minimal change disease (MCD) for several decades. This factor was able to induce MCD-like alterations in kidney tissue in vitro, i.e. impairment of glomerular polyanion (GPA), as well as glomerular ecto-ATPase. We conducted permeability studies using alternate perfusion of the rat kidney ex vivo according to standard techniques. Either native 100 KF (n = 7) or control factor (n = 7) perfusion, followed by perfusion with diluted rat serum was carried out, while urine samples were collected by ureter cannulation. Total urinary protein (by spectrophotometry) as well as IgG (by ELISA) and albumin (by rocket electrophoresis) were measured. Sections of perfused kidneys were stained (immuno-) histochemically for GPA and glomerular ecto-ATPase, and the stainability was quantified using image analysis and expressed as arbitrary units. The results show significantly increased protein leakage after perfusion of 100 KF versus control factor (150.0 +/- 48.9 vs. 33.2 +/- 7.7 micrograms/min, p < or = 0.01), while the IgG/albumin ratio has decreased (12.0 +/- 9.4 vs 26.9 +/- 14.4%, p < or = 0.01). Plasma protein leakage after 100KF perfusion is associated with a significant loss of GPA (57.3 +/- 27.5 vs. 98.4 +/-12.0, p < or = 0.01) and significant decrease of glomerular ecto-ATPase expression (28.7 +/- 11.5 vs. 79.5 +/- 15.0, p < or = 0.001). The capability of 100KF to induce MCD-like glomerular lesions, in association with selectively increased permeability for plasma proteins, suggests that this human plasma constituent may be important in the pathogenesis of MCD.

摘要

几十年来,包括先前描述的血浆蛋白酶(100 KF)在内的循环因子一直被怀疑在微小病变肾病(MCD)的发病机制中起作用。该因子能够在体外诱导肾组织出现类似MCD的改变,即肾小球多阴离子(GPA)以及肾小球外ATP酶受损。我们根据标准技术对大鼠肾脏进行离体交替灌注,开展通透性研究。分别进行天然100 KF(n = 7)或对照因子(n = 7)灌注,随后用稀释的大鼠血清灌注,同时通过输尿管插管收集尿液样本。测量总尿蛋白(通过分光光度法)以及IgG(通过ELISA法)和白蛋白(通过火箭电泳法)。对灌注肾脏的切片进行GPA和肾小球外ATP酶的免疫组织化学染色,并使用图像分析对染色性进行定量,以任意单位表示。结果显示,与对照因子相比,100 KF灌注后蛋白渗漏显著增加(150.0±48.9对33.2±7.7微克/分钟,p≤0.01),而IgG/白蛋白比值降低(12.0±9.4对26.9±14.4%,p≤0.01)。100 KF灌注后的血浆蛋白渗漏与GPA的显著丢失(57.3±27.5对98.4±12.0,p≤0.01)以及肾小球外ATP酶表达的显著降低(28.7±11.5对79.5±15.0,p≤0.001)相关。100 KF诱导类似MCD的肾小球病变的能力,与血浆蛋白选择性通透性增加相关,表明这种人类血浆成分可能在MCD的发病机制中起重要作用。

相似文献

1
Minimal change-like glomerular alterations induced by a human plasma factor.一种人类血浆因子诱导的微小病变样肾小球改变。
Nephron. 1996;74(3):586-93. doi: 10.1159/000189457.
2
Oxygen-dependent injury by a human plasma factor associated with minimal change disease.与微小病变病相关的人血浆因子引起的氧依赖性损伤。
Pediatr Nephrol. 1998 Aug;12(6):452-8. doi: 10.1007/s004670050486.
3
Impairment of endothelial and subendothelial sites by a circulating plasma factor associated with minimal change disease.与微小病变病相关的循环血浆因子对内皮和内皮下部位的损害。
Nephrol Dial Transplant. 1996 Nov;11(11):2185-91. doi: 10.1093/oxfordjournals.ndt.a027135.
4
Induction of experimental proteinuria in vivo following infusion of human plasma hemopexin.输注人血浆血红素结合蛋白后在体内诱导实验性蛋白尿
Kidney Int. 2000 Apr;57(4):1512-20. doi: 10.1046/j.1523-1755.2000.00996.x.
5
Is 100KF an isoform of hemopexin? Immunochemical characterization of the vasoactive plasma factor 100KF.100KF是血红素结合蛋白的一种同工型吗?血管活性血浆因子100KF的免疫化学特性。
J Am Soc Nephrol. 1999 Aug;10(8):1700-8. doi: 10.1681/ASN.V1081700.
6
The glomerular polyanion (GPA) of the rat kidney II. GPA loss in vitro by a vasoactive serum fraction.大鼠肾脏的肾小球多阴离子(GPA)II. 血管活性血清组分导致的体外GPA丢失
Br J Exp Pathol. 1982 Oct;63(5):531-8.
7
[Changes in glomerular polyanions and ultrastructure induced by protamine in rats].
Hua Xi Yi Ke Da Xue Xue Bao. 1992 Sep;23(3):272-5.
8
Protease activity of plasma hemopexin.血浆血红素结合蛋白的蛋白酶活性。
Kidney Int. 2005 Aug;68(2):603-10. doi: 10.1111/j.1523-1755.2005.00438.x.
9
Assessment of urinary angiotensinogen as a marker of podocyte injury in proteinuric nephropathies.评估尿血管紧张素原作为蛋白尿性肾病中足细胞损伤标志物的作用。
Am J Physiol Renal Physiol. 2016 Feb 15;310(4):F322-33. doi: 10.1152/ajprenal.00260.2015. Epub 2015 Dec 2.
10
Unilateral renal disease in the rat. I. Clinical, morphologic, and glomerular mesangial functional features of the experimental model produced by renal perfusion with aminonucleoside.大鼠单侧肾脏疾病。I. 用氨基核苷肾灌注所产生的实验模型的临床、形态学及肾小球系膜功能特征
J Lab Clin Med. 1975 May;85(5):756-68.

引用本文的文献

1
"Idiopathic" minimal change nephrotic syndrome: a podocyte mystery nears the end.特发性微小病变肾病综合征:足细胞之谜即将揭晓。
Am J Physiol Renal Physiol. 2023 Dec 1;325(6):F685-F694. doi: 10.1152/ajprenal.00219.2023. Epub 2023 Oct 5.
2
Involvement of Hemopexin in the Pathogenesis of Proteinuria in Children with Idiopathic Nephrotic Syndrome.血色素结合蛋白在特发性肾病综合征患儿蛋白尿发病机制中的作用
J Clin Med. 2021 Jul 17;10(14):3160. doi: 10.3390/jcm10143160.
3
Pathogenesis of proteinuria in idiopathic minimal change disease: molecular mechanisms.
特发性微小病变病蛋白尿的发病机制:分子机制
Pediatr Nephrol. 2016 Dec;31(12):2179-2189. doi: 10.1007/s00467-016-3379-4. Epub 2016 Jul 6.
4
Hemopexin induces nephrin-dependent reorganization of the actin cytoskeleton in podocytes.血红素结合蛋白诱导足细胞中肌动蛋白细胞骨架的nephrin依赖性重组。
J Am Soc Nephrol. 2008 Nov;19(11):2140-9. doi: 10.1681/ASN.2007080940. Epub 2008 Aug 27.